Related Experiment Video
Updated: Aug 31, 2025

09:50
Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
Published on: December 22, 2023
1.8K
Drug counterfeiting and decentralized whistleblowers
Hossein Omidian1, Yadollah Omidi1
1College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
Drug Discovery Today
|August 22, 2022
Summary
The US Food and Drug Administration (FDA) is piloting blockchain technology to combat drug counterfeiting. Additional global strategies are needed to ensure medication safety and accessibility worldwide.
Area of Science:
- Pharmaceutical supply chain management
- Blockchain technology applications
- Global health security
Background:
- Drug counterfeiting poses a significant global health threat.
- Existing supply chain vulnerabilities facilitate counterfeit drug distribution.
- Technological solutions are being explored to enhance drug traceability.
Purpose of the Study:
- To introduce the US Food and Drug Administration's (FDA) pilot project using blockchain for drug supply chain security.
- To highlight the potential of blockchain technology in tracking and tracing pharmaceutical deliveries.
- To propose complementary strategies for combating drug counterfeiting globally.
Main Methods:
- Implementation of a pilot project involving 24 pharmaceutical supply chain companies.
- Utilizing blockchain technology to track and trace drug deliveries across various stakeholders.
- Analysis of the potential impact of technological adoption on drug counterfeiting.
Main Results:
- The FDA's pilot project demonstrates the application of blockchain in pharmaceutical track-and-trace systems.
- Blockchain offers a robust mechanism for enhancing transparency and security in the drug supply chain.
- The study underscores the need for a multi-faceted approach beyond technology.
Conclusions:
- Blockchain technology is a valuable tool in the fight against counterfeit drugs.
- Governments and pharmaceutical companies should collaborate to implement blockchain infrastructure globally.
- Expanding access to affordable medications through international cooperation and local manufacturing is crucial for global health equity.
Related Concept Videos
Pharmacovigilance
970
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
970
Drug Control Governance: Regulatory Bodies and Their Impact
231
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
231
Drug Regulation
1.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.7K
Deindividuation
27.0K
Deindividuation is a form of social influence on an individual’s behavior such that the individual engages in unusual or non-normal behavior while in a group setting. Why? Because in these group settings, the individual no longer sees themselves as an individual anymore, disinhibiting their behavior and personal restraint.
27.0K
Prescription, Nonprescription and Orphan Drugs
837
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
837
Drug Nomenclature
2.1K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.1K

